Matches in SemOpenAlex for { <https://semopenalex.org/work/W2995359742> ?p ?o ?g. }
Showing items 1 to 78 of
78
with 100 items per page.
- W2995359742 endingPage "S788" @default.
- W2995359742 startingPage "S787" @default.
- W2995359742 abstract "Emergency access to drug technologies (RDTL) was introduced in Poland in 2017 in order to improve patient access to expensive, rescue therapies. The procedure is initiated by hospitals and pertains to single patients. In reality, by mid 2018, few patients (8,5% of total applications) received drugs within this procedure. The aim of this study was to discuss the reasons for it. A search was conducted in grey literature to identify the most important limitations of RDTL. Several limitations of RDTL were identified. The first is administrative burden. It is required that the procedure is initiated by a physician who is obliged to document precisely all previous treatment history. Hospitals do not have additional resources to cover this task, therefore some hospitals are not willing to engage in it. In addition, there is no extra budget for RDTL and hospitals are expected to finance RDTL within the lump sum they receive from National Health Fund. This may endanger hospitals’ financial stability and makes hospitals reluctant to submit RDTL applications. For drugs exceeding the cost threshold, MoH is required to ask for opinion of AHTAPol. This threshold is low (25% of GDP per capita) therefore many applications have to follow this path. AHTAPol has 30 days for issuing opinion that prolongs all procedure, which was supposed to be fast (14 days for basic procedure). If positive opinion is granted by AHTAPol, MoH is obliged to call the manufacturer to submit regular reimbursement application within 90 days, if this is not fulfilled, reimbursement is stopped. Low RDTL utilization is caused by several hurdles that exist to its implementation. These include high administrative and more importantly budget burden to hospitals, low drug cost threshold that implies AHTAPol evaluation and discontinuation of financing if no reimbursement application is received from manufacturer." @default.
- W2995359742 created "2019-12-26" @default.
- W2995359742 creator A5006481072 @default.
- W2995359742 creator A5017566998 @default.
- W2995359742 creator A5021893934 @default.
- W2995359742 creator A5044839175 @default.
- W2995359742 date "2019-11-01" @default.
- W2995359742 modified "2023-09-26" @default.
- W2995359742 title "PNS157 WHY EMERGENCY ACCESS TO DRUG TECHNOLOGES IN POLAND DOES NOT WORK?" @default.
- W2995359742 doi "https://doi.org/10.1016/j.jval.2019.09.2058" @default.
- W2995359742 hasPublicationYear "2019" @default.
- W2995359742 type Work @default.
- W2995359742 sameAs 2995359742 @default.
- W2995359742 citedByCount "0" @default.
- W2995359742 crossrefType "journal-article" @default.
- W2995359742 hasAuthorship W2995359742A5006481072 @default.
- W2995359742 hasAuthorship W2995359742A5017566998 @default.
- W2995359742 hasAuthorship W2995359742A5021893934 @default.
- W2995359742 hasAuthorship W2995359742A5044839175 @default.
- W2995359742 hasBestOaLocation W29953597421 @default.
- W2995359742 hasConcept C10138342 @default.
- W2995359742 hasConcept C127413603 @default.
- W2995359742 hasConcept C127598652 @default.
- W2995359742 hasConcept C144133560 @default.
- W2995359742 hasConcept C160735492 @default.
- W2995359742 hasConcept C162118730 @default.
- W2995359742 hasConcept C162324750 @default.
- W2995359742 hasConcept C182306322 @default.
- W2995359742 hasConcept C18762648 @default.
- W2995359742 hasConcept C187736073 @default.
- W2995359742 hasConcept C21547014 @default.
- W2995359742 hasConcept C2779703844 @default.
- W2995359742 hasConcept C2780451532 @default.
- W2995359742 hasConcept C2908647359 @default.
- W2995359742 hasConcept C50522688 @default.
- W2995359742 hasConcept C545542383 @default.
- W2995359742 hasConcept C71924100 @default.
- W2995359742 hasConcept C78519656 @default.
- W2995359742 hasConcept C99454951 @default.
- W2995359742 hasConceptScore W2995359742C10138342 @default.
- W2995359742 hasConceptScore W2995359742C127413603 @default.
- W2995359742 hasConceptScore W2995359742C127598652 @default.
- W2995359742 hasConceptScore W2995359742C144133560 @default.
- W2995359742 hasConceptScore W2995359742C160735492 @default.
- W2995359742 hasConceptScore W2995359742C162118730 @default.
- W2995359742 hasConceptScore W2995359742C162324750 @default.
- W2995359742 hasConceptScore W2995359742C182306322 @default.
- W2995359742 hasConceptScore W2995359742C18762648 @default.
- W2995359742 hasConceptScore W2995359742C187736073 @default.
- W2995359742 hasConceptScore W2995359742C21547014 @default.
- W2995359742 hasConceptScore W2995359742C2779703844 @default.
- W2995359742 hasConceptScore W2995359742C2780451532 @default.
- W2995359742 hasConceptScore W2995359742C2908647359 @default.
- W2995359742 hasConceptScore W2995359742C50522688 @default.
- W2995359742 hasConceptScore W2995359742C545542383 @default.
- W2995359742 hasConceptScore W2995359742C71924100 @default.
- W2995359742 hasConceptScore W2995359742C78519656 @default.
- W2995359742 hasConceptScore W2995359742C99454951 @default.
- W2995359742 hasLocation W29953597421 @default.
- W2995359742 hasOpenAccess W2995359742 @default.
- W2995359742 hasPrimaryLocation W29953597421 @default.
- W2995359742 hasRelatedWork W1980800672 @default.
- W2995359742 hasRelatedWork W2019291989 @default.
- W2995359742 hasRelatedWork W2078189442 @default.
- W2995359742 hasRelatedWork W2166521090 @default.
- W2995359742 hasRelatedWork W2319748522 @default.
- W2995359742 hasRelatedWork W2355659848 @default.
- W2995359742 hasRelatedWork W2404315566 @default.
- W2995359742 hasRelatedWork W2898528389 @default.
- W2995359742 hasRelatedWork W2899084033 @default.
- W2995359742 hasRelatedWork W3120994991 @default.
- W2995359742 hasVolume "22" @default.
- W2995359742 isParatext "false" @default.
- W2995359742 isRetracted "false" @default.
- W2995359742 magId "2995359742" @default.
- W2995359742 workType "article" @default.